Analyst: A 'Risk/Benefit Conundrum'
Safety Issues Diminish Impact of Oral MS Therapy Data at AAN
By Jennifer Boggs Friday, May 1, 2009
No Abstract
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
